Qiagen NV | QIA - Cash And Equivalent

Stock Price
41.39
Daily Change
0.21 0.51%
Monthly
-9.00%
Yearly
11.07%
Q1 Forecast
40.37

Qiagen NV reported $1.36B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
argenx SE USD 4.3B 2.21B Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025